Special Issue "Pharmacists' Interventions to Optimise Patient Care"

A special issue of Pharmacy (ISSN 2226-4787).

Deadline for manuscript submissions: closed (30 November 2020) | Viewed by 1509

Special Issue Editor

Dr. Laura Jane Sahm
E-Mail Website
Guest Editor
School of Pharmacy, University College Cork, Cork T12 YN60, Ireland
Interests: pharmacovigilance; public health; health literacy; appropriate prescribing; deprescribing

Special Issue Information

Dear Colleagues,

I am delighted to be Guest Editor of this Special Issue “Pharmacists' Interventions to Optimise Patient Care” of Journal Pharmacy. The World Health Organization (WHO) has launched its third global patient safety challenge, Medication Without Harm, which focuses on improving medication safety. The goal of the WHO challenge is to reduce severe, avoidable harm related to medicines by 50% in the next 5 years. Pharmacists have the unique skillset and competencies to rise to this challenge—we are the healthcare professionals who have the knowledge, expertise, and attitudes to be able to optimise patient care regarding medications.

The global challenge aims to encourage and enable patients, their caregivers, and healthcare professionals (for example nurses, physicians, pharmacists) to take an active role in ensuring safer medication practices and medication use processes including prescribing, preparation, dispensing, administration, and monitoring.

Articles in this Special Issue will focus on the pharmacist as a leader, team member, and collaborator within the multidisciplinary team, and can include quantitative, qualitative, and mixed-methods studies. I know that there are many initiatives happening within the community and hospital settings, and I would be delighted to be able to feature these in order to raise awareness and foster further research publications in this valuable area.

Dr. Laura Jane Sahm
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • medication safety;
  • medication reconciliation;
  • polypharmacy;
  • transition of patients;
  • health literacy

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:


Heart Failure Prescribing Quality at Discharge from a Critical Care Unit in Egypt: The Impact of Multidisciplinary Care
Pharmacy 2020, 8(3), 159; https://doi.org/10.3390/pharmacy8030159 - 01 Sep 2020
Cited by 2 | Viewed by 1296
Discharge prescriptions for heart failure (HF) patients may not adhere to the clinical practice guidelines. This study aimed to assess the impact of the clinical pharmacist as a member of a multidisciplinary team on the quality of prescribing to HF patients at discharge [...] Read more.
Discharge prescriptions for heart failure (HF) patients may not adhere to the clinical practice guidelines. This study aimed to assess the impact of the clinical pharmacist as a member of a multidisciplinary team on the quality of prescribing to HF patients at discharge from a Critical Care Unit (CCU) in Egypt. This was a retrospective cohort study of HF patients discharged from the CCU between January 2013 and December 2017. Guideline Adherence Index (GAI-3) was used to assess guideline-directed prescribing at discharge. Multidisciplinary care was introduced to the CCU on 1 January 2016. The study included 284 HF patients, mean (±SD) age 66.7 ± 11.5 years, 53.2% male. Heart failure with reduced ejection fraction affected 100 patients (35.2%). At discharge, loop diuretics were prescribed to 85.2% of patients; mineralocorticoid receptor antagonists to 54.9%; angiotensin-converting enzyme inhibitors/angiotensin receptor blockers to 51.4%; and β-blockers to 29.9%. Population Guideline Adherence Index (GAI-3) was 45.5%. High-GAI was prescribed to 136 patients (47.9%). Patients with High-GAI were younger; less affected by chronic kidney disease and had fewer comorbidities than those without High-GAI. Prescription of β-blocker increased (24.1% vs. 38.6%, p < 0.001) and digoxin utilization decreased (34.7% vs. 23.7%, p < 0.049) after the introduction of the multidisciplinary care. The inclusion of a clinical pharmacist in the multidisciplinary care team may have a role in optimizing the prescribing of HF guideline-directed therapies at discharge from this setting. Full article
(This article belongs to the Special Issue Pharmacists' Interventions to Optimise Patient Care)
Show Figures

Figure 1

Back to TopTop